In these circumstances, the activation of NrF2 and tHO-1 at the nuclear level is actively used by cancer cells as a protective system against oxidative and ER stress to sustain cell survival and the acquisition of a more aggressive tumour phenotype. Here, NFE2L2 is linked to neoplasm.